Insurance Fraud in Transgender Medicine
Insurance fraud is a widespread issue in transgender medicine, with evidence of billing fraud prompting a nationwide investigation by the Trump administration.
A key strategy in the administration's crackdown on gender medicine involves identifying and prosecuting insurance fraud, particularly in cases where the diagnosis "Endocrine Disorder Not Otherwise Specified" (E34.9) is used instead of "Gender Identity Disorders" (F64) for patients without endocrine disorders.
The "gender dysphoria" diagnosis was created in 2013 to ensure insurance coverage for medical interventions.
Critics argue that fraud may exist even with proper diagnostic coding, citing the creation of the "gender dysphoria" diagnosis as a means to secure insurance coverage.
Author's summary: Insurance fraud plagues transgender medicine.